Andres Stephano-Quintanar
C.p
Aguascalientes, AGU 20131, Mexico
Aguascalientes, AGU 20131, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Design, Synthesis, and Proof-of-Concept Bioassay of an Encapsulated mRNA for Human Growth Hormone.
Journal: Current issues in molecular biology
Published: April 24, 2026
Long-Term Hepatorenal Toxicity Assessment of the Vasopressin Receptor Antagonist Conivaptan in Lewis Rats: Implications for Therapeutic Safety.
Journal: Journal of applied toxicology : JAT
Published: April 13, 2026
Pituitary Neurolobectomy induces sustained hypotension in male Wistar rats and normalizes blood pressure in male spontaneously hypertensive rats.
Journal: Physiological reports
Published: January 29, 2026
Effects of arginine vasopressin deficiency on cardiac fibrosis in male Wistar rats.
Journal: Physiological reports
Published: November 20, 2025
N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer.
Journal: Biomedicines
Published: October 07, 2025
Portacaval anastomosis promotes fragmentation of mitochondrial network in the cerebellum of male rats.
Journal: Metabolic brain disease
Published: February 10, 2025
Neurological recovery in rats with portocaval anastomosis-induced hepatic encephalopathy treated with leuprolide acetate, a GnRH agonist.
Journal: Metabolic brain disease
Published: June 07, 2024
Analysis of hippocampus in rats with acute brain ischemia-reperfusion injury treated with leuprolide acetate, an agonist of GnRH.
Journal: Restorative neurology and neuroscience
Published: June 25, 2023
Effect of Leuprolide Acetate, a GnRH Agonist, on Neuroinflammation and Anxiety-Like Behavior after Mild Hypoxic-Ischemic Encephalopathy in Rat Model.
Journal: Neuroimmunomodulation
Published: May 12, 2023
Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment.
Journal: Frontiers in neuroscience
Published: January 05, 2023
Arginine vasopressin deficiency and conivaptan (a V1a-V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis.
Journal: International journal of experimental pathology
Published: November 12, 2022
Last Updated: 09/26/2026